Literature DB >> 30510314

Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.

Francesco Zublena1, Alice Tamborini1, Carmel T Mooney1, Susan M North1, Monika A Lobacz1, Dan Andrew1, Vanessa Woolhead1, Heather Covey1, Herbert A Schmid1, David B Church1, Stijn J M Niessen1.   

Abstract

An 8-year-old castrated male border terrier dog was diagnosed with acromegaly resulting from a growth hormone secreting pituitary tumor. Sixteen daily fractions of radiation therapy were delivered followed, approximately 1 year later, by administration of pasireotide. The aforementioned treatment was considered effective and should be further evaluated in similar cases.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30510314      PMCID： PMC6135304     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  32 in total

Review 1.  Secretion of prolactin and growth hormone in relation to ovarian activity in the dog.

Authors:  H S Kooistra; A C Okkens
Journal:  Reprod Domest Anim       Date:  2001-08       Impact factor: 2.005

2.  The computed tomographic enhancement pattern of the normal canine pituitary gland.

Authors:  N E Love; P Fisher; L Hudson
Journal:  Vet Radiol Ultrasound       Date:  2000 Nov-Dec       Impact factor: 1.363

3.  Primary hypothyroidism in dogs is associated with elevated GH release.

Authors:  W M Lee; M Diaz-Espineira; J A Mol; A Rijnberk; H S Kooistra
Journal:  J Endocrinol       Date:  2001-01       Impact factor: 4.286

4.  Hypothyroidism associated with acromegaly and insulin-resistant diabetes mellitus in a Samoyed.

Authors:  T Johnstone; E Terzo; C T Mooney
Journal:  Aust Vet J       Date:  2014-10-07       Impact factor: 1.281

5.  Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial.

Authors:  S Petersenn; J Schopohl; A Barkan; P Mohideen; A Colao; R Abs; A Buchelt; Y-Y Ho; K Hu; A J Farrall; S Melmed; B M K Biller
Journal:  J Clin Endocrinol Metab       Date:  2010-04-21       Impact factor: 5.958

6.  Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism.

Authors:  Jeanette M Hanson; Hoofd Martine M van 't; George Voorhout; Erik Teske; Hans S Kooistra; Björn P Meij
Journal:  J Vet Intern Med       Date:  2005 Sep-Oct       Impact factor: 3.333

7.  Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.

Authors:  Victor Castillo; Marily Theodoropoulou; Johanna Stalla; Maria Florencia Gallelli; Maria Fernanda Cabrera-Blatter; Mariana R Haedo; Marta Labeur; Herbert A Schmid; Günter K Stalla; Eduardo Arzt
Journal:  Neuroendocrinology       Date:  2011-04-28       Impact factor: 4.914

Review 8.  Hypersomatotropism, acromegaly, and hyperadrenocorticism and feline diabetes mellitus.

Authors:  Stijn J M Niessen; David B Church; Yaiza Forcada
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-03       Impact factor: 2.093

9.  Cross-sectional imaging characteristics of pituitary adenomas, invasive adenomas and adenocarcinomas in dogs: 33 cases (1988-2006).

Authors:  Rachel E Pollard; Christopher M Reilly; Megan R Uerling; Farica D Wood; Edward C Feldman
Journal:  J Vet Intern Med       Date:  2010 Jan-Feb       Impact factor: 3.333

10.  Feline acromegaly: an underdiagnosed endocrinopathy?

Authors:  S J M Niessen; G Petrie; F Gaudiano; M Khalid; J B A Smyth; P Mahoney; D B Church
Journal:  J Vet Intern Med       Date:  2007 Sep-Oct       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.